secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K/A
Filed at:   2024-01-25T23:59:59+00:00
Accession:  0001493152-24-003751
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem amends prior 8-K to fix exhibit link for Series F-1 Preferred Stock certificate
--------------------------------------------------------------------------------

- Filing corrects reference to Certificate of Designation of Series F-1 Preferred Stock.
- Original merger agreement with Aditxt reported on Dec 27, 2023 remains unchanged.
- No financial impact or change to merger terms from this technical amendment.
- Exhibit 3.1 now properly incorporated by reference to Dec 12, 2023 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000149315224003751/0001493152-24-003751-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000149315224003751/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-003751

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer